Likang gets trial ok for China’s first personalized cancer vaccine
Likang Life Sciences has received implied approval for the clinical trial of its personalized neoantigen-targeted…
Likang Life Sciences has received implied approval for the clinical trial of its personalized neoantigen-targeted…
This week our guests are Marit Inngjerdingen from the Institute of Clinical Medicine in Norway;…
AELIX Therapeutics S.L., a clinical-stage biotechnology company specializing in the discovery and development of immunotherapies…
Immuno Cure BioTech, a clinical stage biotechnology group based in the Hong Kong Science Park,…
Scancell Holdings plc, which develops novel immunotherapies for the treatment of cancer and infectious disease,…
The first vaccine to potentially prevent Staphylococcal-induced toxic shock syndrome (TSS) has successfully completed a…
Researchers from global health system Cleveland Clinic have launched the next step in their novel…
The Access to Advanced Health Institute (AAHI) has been awarded a project agreement worth up…
pHion Therapeutics is a U.K.-based vaccine development company. It is developing a pipeline of therapeutic…
A new Memorandum of Understanding (MoU) to facilitate collaboration in the field of pandemic preparedness…
ErVaccine Technologies, announces the closing of a €4.5 million ($4.8 million) seed round, including dilutive…
Ethris GmbH is to collaborate with U.K.-based DIOSynVax to jointly develop a protective mRNA vaccine…